The costs of drug prescriptions for diabetes in the NHS

Stedman, Mike; Lunt, Mark; Livingston, Mark; Fryer, Anthony A; Moreno, Gabriela; Bailey, Susan; Gadsby, Roger; Heald, Adrian

doi:10.1016/s0140-6736(18)33190-8

The costs of drug prescriptions for diabetes in the NHS

Stedman, Mike; Lunt, Mark; Livingston, Mark; Fryer, Anthony A; Moreno, Gabriela; Bailey, Susan; Gadsby, Roger; Heald, Adrian

Authors

Mike Stedman

Mark Lunt

Mark Livingston

Professor Anthony Fryer a.a.fryer@keele.ac.uk

Gabriela Moreno

Susan Bailey

Roger Gadsby

Adrian Heald

Citation

Stedman, M., Lunt, M., Livingston, M., Fryer, A. A., Moreno, G., Bailey, S., …Heald, A. (2019). The costs of drug prescriptions for diabetes in the NHS. The Lancet, 393(10168), 226-227. https://doi.org/10.1016/s0140-6736%2818%2933190-8

Journal Article Type	Article
Online Publication Date	Jan 17, 2019
Publication Date	2019-01
Deposit Date	Jun 13, 2023
Journal	The Lancet
Print ISSN	0140-6736
Publisher	Elsevier
Peer Reviewed	Peer Reviewed
Volume	393
Issue	10168
Pages	226-227
DOI	https://doi.org/10.1016/s0140-6736%2818%2933190-8
Keywords	General Medicine
PMID	30663590

Monitoring drug interventions in people with bipolar disorder (2023)
Journal Article

Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a 'Nearly Post COVID-19' World (2022)
Presentation / Conference

Speed of recovery of testing for management of diabetes in the aftermath of COVID-19 is slower in areas of greater social deprivation: findings from a UK study (2022)
Presentation / Conference

Variability in test interval is linked to glycated haemoglobin (HbA1c) trajectory over time in people with diabetes (2022)
Presentation / Conference

The pattern of testing for glycosylated haemoglobin (HbA 1c ) in people with diabetes is linked to the long term trajectory of blood glucose control (2021)
Presentation / Conference

Downloadable Citations

HTML

BIB

RTF

Authors

Citation

You might also like

Downloadable Citations